CDP has just opened a brand-new biological laboratory at its Cambridge HQ, certified to allow research on containment level 2 biological hazards such as micro-organisms, blood and other body products. ‘We are delighted to announce that our new lab has now received approval from the UK Health and Safety Executive,’…
Biosimilars are taking on the multi-billion-dollar blockbuster drugs of today, with some sources suggesting that the market will be worth greater than $20 billion per annum within the next couple of years. The growth is being driven by factors such as healthcare systems looking to reduce costs and the growing…
The recent Digital Health World Congress 2018, which was held in London at the end of November, covered aspects of medical and mobile technology. It certainly presented an interesting and diverse line-up of speakers and exhibitors. A key learning we took from the event is that digital health (the intersection…
With inhaler use notoriously prone to user error, any clinical study that involves self-administration via an inhaler is challenging from the outset. Help is at hand, however, with a simple-but-smart device developed by Cambridge Design Partnership “So many things can go wrong when an inhaler is used to deliver a…
Recently we have been investigating how sleep trends are impacting consumers and how companies can develop new solutions to help us all to sleep better. There is growing scientific evidence, media coverage and public awareness of the impact of sleep on our health. Not just how you feel today, but…
How fast is fast? I’ve always been told that when it comes to drug delivery devices, ‘fast’ development is usually measured in years rather than months – with additional years for industrialisation and transfer to manufacturing. In fact, there are drug delivery devices which have been in development for more…
Any company wants their customers to covet and love their products or services because this is the way to becoming the market leader. But for products used by healthcare professionals (HCPs) in a clinical setting, usability is traditionally associated with safety. With so many regulations to meet, delighting the user…
Most of us don’t take action often enough when it comes to improving our health. For many, the standard of care is bare bones: we find the time to schedule a visit to the doctor, listen attentively for the few minutes the doctor is speaking, and then implement the one…
Our healthcare clients do amazing work on complex designs with strict oversight and regulations – which are necessary to ensure medical products are safe and efficacious. But when we collaborate, our combined teams can greatly accelerate programmes, prompting the common question: “What are we doing to move so fast together?”Having…
www.linkedin.com/in/conor-devine-0566b286/As Europe’s dedicated pharmaceutical packaging and drug delivery event, Pharmapack is the industry’s go-to place to kick off the year. At least that’s what the event website says and, after my visit, I’m inclined to agree. With 411 companies exhibiting their services in everything from primary, secondary and tertiary packaging…
Coming back from the Christmas and New Year break, I realised how blessed I am. I’m in good health, I’ve been able to spend enjoyable time with my family and I’ve now returned to my exciting job surrounded by a team of enthusiastic and very smart people. For many people,…
Currently, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) is responsible for just under a third of applications and updates for European medicinal product marketing authorisations – but on 29 March 2019 the UK will no longer be part of the European Union (EU). I was struck by the enormity…